DoW Reconstructive Transplant, Investigator-Initiated Research Award
Defense Health Agency Contracting Activity - DHACA
Free. Verify your email, then we send one reminder only.
- Posted
- Aug 4, 2026
- Closes
- Nov 4, 2026 (in 69 days)
Similar opportunities open now
- DOW Combat Readiness – Medical Research Program Translational Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 83 days
- DoW Alzheimer’s Transforming Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 28 days
- DoW Traumatic Brain Injury and Psychological Health, Translational Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 49 days
- DoW Duchenne Muscular Dystrophy, Clinical/Translational Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 22 days
- DoW Alzheimer’s Transforming Diagnosis AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 28 days
Classification and identifiers
- Solicitation number
- HT942526RTRPIIRA
- Assistance listing (CFDA)
- 12.420
Amount
Amount not published by the funder
Who can apply
About this opportunity
Summary: The fiscal year 2026 (FY26) Reconstructive Transplant Research Program (RTRP) Investigator-Initiated Research Award supports studies that have the potential to make an important contribution to reconstructive transplant research, patient care, and/or quality of life. All projects must demonstrate solid scientific rationale with military-relevant utility. The Investigator-Initiated Research Award does not support clinical trials . Distinctive Features: · Scope: Applications may focus on any phase of research from basic through translational, including preclinical studies in animal models, and clinical research in human subjects or human anatomical substances. · Study Design and Feasibility: The study design should be rigorous and support maximal reproducibility and translational fe...